1. |
Microsurgery Department of the Orthopedics Branch of the Chinese Medical Doctor Association. Chinese guideline for the diagnosis and treatment of osteonecrosis of the femoral head in adults. Orthop Surg, 2017, 9(1): 3-12.
|
2. |
Zhao D, Zhang F, Wang B, et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version). J Orthop Translat, 2020, 21: 100-110.
|
3. |
Kubo T, Ueshima K, Saito M, et al. Clinical and basic research on steroid-induced osteonecrosis of the femoral head in Japan. J Orthop Sci, 2016, 21(4): 407-413.
|
4. |
Zhang QY, Li ZR, Gao FQ, et al. Pericollapse stage of osteonecrosis of the femoral head: A Last chance for joint preservation. Chin Med J (Engl), 2018, 131(21): 2589-2598.
|
5. |
Liu LH, Zhang QY, Sun W, et al. Corticosteroid-induced osteonecrosis of the femoral head: Detection, diagnosis, and treatment in earlier stages. Chin Med J (Engl), 2017, 130(21): 2601-2607.
|
6. |
Hardy RS, Zhou H, Seibel MJ, et al. Glucocorticoids and bone: Consequences of endogenous and exogenous excess and replacement therapy. Endocr Rev, 2018, 39(5): 519-548.
|
7. |
Weinstein RS, Hogan EA, Borrelli MJ, et al. The pathophysiological sequence of glucocorticoid-induced osteonecrosis of the femoral head in male mice. Endocrinology, 2017, 158(11): 3817-3831.
|
8. |
Wang A, Ren M, Wang J. The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature. Gene, 2018, 671: 103-109.
|
9. |
Fang SH, Chen L, Chen HH, et al. MiR-15b ameliorates SONFH by targeting Smad7 and inhibiting osteogenic differentiation of BMSCs. Eur Rev Med Pharmacol Sci, 2019, 23(22): 9761-9771.
|
10. |
刘立华, 孙伟, 王云亭, 等. 头颈部开窗减压治疗 L1 型激素性股骨头坏死: 单中心前瞻性临床研究. 中国组织工程研究, 2021, 25(6): 906-911.
|
11. |
中国医师协会骨科医师分会骨循环与骨坏死专业委员会, 中华医学会骨科分会骨显微修复学组, 国际骨循环学会中国区. 中国成人股骨头坏死临床诊疗指南 (2020). 中华骨科杂志, 2020, 40(20): 1365-1376.
|
12. |
Barile L, Vassalli G. Exosomes: Therapy delivery tools and biomarkers of diseases. Pharmacol Ther, 2017, 174: 63-78.
|
13. |
Liao W, Du Y, Zhang C, et al. Exosomes: The next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater, 2019, 86: 1-14.
|
14. |
Qin Y, Sun R, Wu C, et al. Exosome: A novel approach to stimulate bone regeneration through regulation of osteogenesis and angiogenesis. Int J Mol Sci, 2016, 17(5): 712.
|
15. |
Masaoutis C, Theocharis S. The role of exosomes in bone remodeling: implications for bone physiology and disease. Dis Markers, 2019, 2019: 9417914.
|
16. |
Behera J, Tyagi N. Exosomes: mediators of bone diseases, protection, and therapeutics potential. Oncoscience, 2018, 5(5-6): 181-195.
|
17. |
Qi X, Zhang J, Yuan H, et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats. Int J Biol Sci, 2016, 12(7): 836-849.
|
18. |
Zhao P, Xiao L, Peng J, et al. Exosomes derived from bone marrow mesenchymal stem cells improve osteoporosis through promoting osteoblast proliferation via MAPK pathway. Eur Rev Med Pharmacol Sci, 2018, 22(12): 3962-3970.
|
19. |
Zhang J, Liu X, Li H, et al. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res Ther, 2016, 7(1): 136.
|
20. |
Lu J, Wang QY, Sheng JG. Exosomes in the repair of bone defects: next-generation therapeutic tools for the treatment of nonunion. Biomed Res Int, 2019, 2019: 1983131.
|
21. |
Song H, Li X, Zhao Z, et al. Reversal of osteoporotic activity by endothelial cell-secreted bone targeting and biocompatible exosomes. Nano Lett, 2019, 19(5): 3040-3048.
|
22. |
Zheng H, Liu J, Tycksen E, et al. MicroRNA-181a/b-1 over-expression enhances osteogenesis by modulating PTEN/PI3K/AKT signaling and mitochondrial metabolism. Bone, 2019, 123: 92-102.
|
23. |
Lin Z, He H, Wang M, et al. MicroRNA-130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate. Cell Prolif, 2019, 52(6): e12688.
|
24. |
Zhang L, Tang Y, Zhu X, et al. Overexpression of MiR-335-5p promotes bone formation and regeneration in mice. J Bone Miner Res, 2017, 32(12): 2466-2475.
|
25. |
Gu C, Xu Y, Zhang S, et al. miR-27a attenuates adipogenesis and promotes osteogenesis in steroid-induced rat BMSCs by targeting PPARγ and GREM1. Sci Rep, 2016, 6: 38491.
|
26. |
Wu X, Gu Q, Chen X, et al. MiR-27a targets DKK2 and SFRP1 to promote reosseointegration in the regenerative treatment of peri-implantitis. J Bone Miner Res, 2019, 34(1): 123-134.
|
27. |
Sriram M, Sainitya R, Kalyanaraman V, et al. Biomaterials mediated microRNA delivery for bone tissue engineering. Int J Biol Macromol, 2015, 74: 404-412.
|
28. |
Arriaga MA, Ding MH, Gutierrez AS, et al. The application of microRNAs in biomaterial scaffold-based therapies for bone tissue engineering. Biotechnology Journal, 2019, 14(10): e1900084.
|
29. |
黎牧帆, 张二洋, 吕雷锋, 等. 维生素 E 对大鼠早期激素性股骨头缺血性坏死的作用及机制研究. 中国修复重建外科杂志, 2018, 32(11): 1421-1428.
|
30. |
Velmurugan BK, Bharathi Priya L, Poornima P, et al. Biomaterial aided differentiation and maturation of induced pluripotent stem cells. J Cell Physiol, 2019, 234(6): 8443-8454.
|
31. |
Bakhshandeh B, Zarrintaj P, Oftadeh MO, et al. Tissue engineering; strategies, tissues, and biomaterials. Biotechnol Genet Eng Rev, 2017, 33(2): 144-172.
|
32. |
Jewell CM, Collier JH. Biomaterial interactions with the immune system. Biomater Sci, 2019, 7(3): 713-714.
|
33. |
Sato Y, Bando H, Di Piazza M, et al. Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider. Cytotherapy, 2019, 21(11): 1095-1111.
|
34. |
Colao IL, Corteling R, Bracewell D, et al. Manufacturing exosomes: A promising therapeutic platform. Trends Mol Med, 2018, 24(3): 242-256.
|
35. |
Adamiak M, Cheng G, Bobis-Wozowicz S, et al. Induced pluripotent stem cell (iPSC)-derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs. Circ Res, 2018, 122(2): 296-309.
|
36. |
Wang B, Jia H, Zhang B, et al. Pre-incubation with hucMSC-exosomes prevents cisplatin-induced nephrotoxicity by activating autophagy. Stem Cell Res Ther, 2017, 8(1): 75.
|
37. |
Zhang S, Liu X, Ge L L, et al. Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling. Respir Res, 2020, 21(1): 71.
|
38. |
Qing L, Chen H, Tang J, et al. Exosomes and their microRNA cargo: New players in peripheral nerve regeneration. Neurorehabil Neural Repair, 2018, 32(9): 765-776.
|
39. |
Zuo R, Kong L, Wang M, et al. Exosomes derived from human CD34 stem cells transfected with miR-26a prevent glucocorticoid-induced osteonecrosis of the femoral head by promoting angiogenesis and osteogenesis. Stem Cell Res Ther, 2019, 10(1): 321.
|
40. |
Qin Y, Wang L, Gao Z, et al. Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo. Sci Rep, 2016, 6: 21961.
|
41. |
Duan Y, Tan Z, Yang M, et al. PC-3-derived exosomes inhibit osteoclast differentiation by downregulating miR-214 and blocking NF-B signaling pathway. Biomed Res Int, 2019, 2019: 8650846.
|
42. |
Gonzalez-King H, García NA, Ontoria-Oviedo I, et al. Hypoxia inducible factor-1α potentiates jagged 1-mediated angiogenesis by mesenchymal stem cell-derived exosomes. Stem Cells, 2017, 35(7): 1747-1759.
|
43. |
Liao W, Ning Y, Xu HJ, et al. BMSC-derived exosomes carrying microRNA-122-5p promote proliferation of osteoblasts in osteonecrosis of the femoral head. Clin Sci (Lond), 2019, 133(18): 1955-1975.
|
44. |
Familtseva A, Jeremic N, Tyagi SC. Exosomes: cell-created drug delivery systems. Mol Cell Biochem, 2019, 459(1-2): 1-6.
|
45. |
Burnouf T, Agrahari V, Agrahari V. Extracellular vesicles as nanomedicine: Hopes and hurdles in clinical translation. Int J Nanomedicine, 2019, 14: 8847-8859.
|
46. |
Zhou B, Peng K, Wang G, et al. miR-483-3p promotes the osteogenesis of human osteoblasts by targeting Dikkopf 2 (DKK2) and the Wnt signaling pathway. Int J Mol Med, 2020, 46(4): 1571-1581.
|
47. |
Watson EC, Adams RH. Biology of bone: The vasculature of the skeletal system. Cold Spring Harb Perspect Med, 2018, 8(7): a031559.
|
48. |
Sivaraj KK, Adams RH. Blood vessel formation and function in bone. Development, 2016, 143(15): 2706-2715.
|
49. |
Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem, 2019, 88: 487-514.
|